|
BMC Pediatrics Volume 9
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools: Post to:
|
 Research articleHyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trialDaniel A Rossignol1 , Lanier W Rossignol1 , Scott Smith1 , Cindy Schneider2 , Sally Logerquist2 , Anju Usman3 , Jim Neubrander4 , Eric M Madren5 , Gregg Hintz6 , Barry Grushkin7 and Elizabeth A Mumper8  1International Child Development Resource Center, Melbourne, FL, USA 2Center for Autism Research and Education, Phoenix, AZ, USA 3True Health Medical Center, Naperville, IL, USA 4Edison, NJ, USA 5Princess Anne Medical Associates, Virginia Beach, VA, USA 6Therapeutic Pathways, East Troy, WI, USA 7Biognosys, Nanuet, NY, USA 8Rimland Center, Lynchburg, VA, USA author email corresponding author email
BMC Pediatrics 2009,
9:21doi:10.1186/1471-2431-9-21 Abstract
Background
Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a controlled study. We performed a multicenter, randomized, double-blind, controlled trial to assess the efficacy of hyperbaric treatment in children with autism.
Methods
62 children with autism recruited from 6 centers, ages 2–7 years (mean 4.92 ± 1.21), were randomly assigned to 40 hourly treatments of either hyperbaric treatment at 1.3 atmosphere (atm) and 24% oxygen ("treatment group", n = 33) or slightly pressurized room air at 1.03 atm and 21% oxygen ("control group", n = 29). Outcome measures included Clinical Global Impression (CGI) scale, Aberrant Behavior Checklist (ABC), and Autism Treatment Evaluation Checklist (ATEC).
Results
After 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0008), receptive language (p < 0.0001), social interaction (p = 0.0473), and eye contact (p = 0.0102); 9/30 children (30%) in the treatment group were rated as "very much improved" or "much improved" compared to 2/26 (8%) of controls (p = 0.0471); 24/30 (80%) in the treatment group improved compared to 10/26 (38%) of controls (p = 0.0024). Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0336), receptive language (p = 0.0168), and eye contact (p = 0.0322). On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability (p = 0.0311). On the ATEC, sensory/cognitive awareness significantly improved (p = 0.0367) in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. Hyperbaric treatment was safe and well-tolerated.
Conclusion
Children with autism who received hyperbaric treatment at 1.3 atm and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.
Trial Registration
clinicaltrials.gov NCT00335790 |